Patents for A61P 33 - Antiparasitic agents (21,787)
07/2009
07/08/2009CN100509810C Substituted beta-carbolines
07/07/2009US7556948 Method for producing crystallized pleuromutilins
07/07/2009US7556829 Method for producing Mallotus philippinensis dye composition and the composition
07/07/2009CA2215641C Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor
07/02/2009WO2009081789A1 Sulfonyl substituted 6-membered ring derivative
07/02/2009WO2009080546A1 The use of 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pyrimidine compounds for combating pests in and on animals
07/02/2009US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof
07/02/2009US20090169574 Heteroclitic analogs and related methods
07/02/2009CA2738403A1 Domestic animal parasite-repellent device
07/02/2009CA2710171A1 The use of 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pyrimidine compounds for combating pests in and on animals
07/02/2009CA2707447A1 Sulfonyl-substituted 6-membered ring derivative
07/01/2009EP2073804A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy
07/01/2009EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
07/01/2009EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/01/2009CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
07/01/2009CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them
07/01/2009CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
06/2009
06/30/2009US7553839 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
06/25/2009WO2009077677A2 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
06/25/2009WO2009077527A1 Anthelmintic agents and their use
06/25/2009WO2009061407A4 Schistosoma vaccine
06/25/2009US20090163575 Solvent systems for pour-on formulations for combating parasites
06/25/2009US20090163540 Quinine Sulfate Polymorphs, Processes of Preparing, Compositions and Uses Thereof
06/25/2009US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
06/25/2009US20090162356 CRIg antagonists
06/25/2009DE102007061262A1 Neue Verwendung von Tribendimidin New use of Tribendimidin
06/25/2009CA2709407A1 Anthelmintic agents and their use
06/24/2009EP1590360A4 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
06/24/2009EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
06/24/2009CN100503560C Substituted cyclohexane derivatives
06/24/2009CN100502882C Application of aescin and its derivative in preparing medicine for treating acute pulmonary inflammation
06/24/2009CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity
06/23/2009CA2389219C Dry powder compositions having improved dispersivity
06/18/2009WO2009058859A3 Dispiro 1,2,4-trioxolane antimalarials
06/18/2009WO2009025919A3 5-propargyl-pyrimidine derivatives as inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties
06/18/2009WO2009010298A3 Paullone derivatives and its use
06/18/2009WO2008072053A8 Substituted arylpyrazoles
06/18/2009WO2008056266A8 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives
06/18/2009US20090156687 Fab I and inhibition of apicomplexan parasites
06/18/2009US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof
06/18/2009US20090155281 Methods of using antibodies that bind both bcma and taci
06/18/2009US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa
06/18/2009US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
06/17/2009EP2071036A2 Methods for identifying RNA-binding compounds
06/17/2009EP2069345A2 Pyridazine and pyrrole compounds, processes for obtaining them and uses
06/17/2009EP1712229B1 Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same
06/16/2009US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis
06/11/2009WO2009072621A1 Substituted dihydroazole compound and pest control agent
06/11/2009WO2009071905A2 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases
06/11/2009WO2009071564A1 Pharmaceutical composition for treating malaria
06/11/2009WO2009071553A1 New therapeutic uses of dual molecules containing a peroxide derivative
06/11/2009WO2003011214A3 Novel methods and formulations for administration of active agents
06/11/2009US20090149515 Treatments for the control of schistosomiasis
06/11/2009US20090149391 Novel antimicrobial bolisin peptides
06/11/2009US20090148477 Adenoviral vector-based malaria vaccines
06/11/2009CA2707245A1 Vaccine
06/10/2009EP2067488A1 Albumin fusion proteins
06/10/2009CN100497639C Means and methods for the production of adenovirus vectors
06/10/2009CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
06/10/2009CN100496605C Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof
06/10/2009CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives
06/09/2009US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
06/04/2009WO2009068623A1 Crystalline form of an antimalarial compound
06/04/2009WO2009067797A1 Cysteine protease inhibitors for the treatment of parasitic diseases
06/04/2009WO2009051796A3 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents
06/04/2009US20090142297 5-substituted isoindoline compounds
06/04/2009DE19549852B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations
06/04/2009CA2706746A1 Cysteine protease inhibitors for the treatment of parasitic diseases
06/04/2009CA2706448A1 Solvent systems for pour-on formulations for combating parasites
06/03/2009EP2065042A2 Antiparasitic composition containing an organic amine salt of closantel
06/03/2009EP1218544B1 TAR RNA binding peptides
06/03/2009EP0772677B1 T cell activation
06/03/2009CN101445504A Dioxane-2-alkyl carbamates derivatives
06/03/2009CN100494182C Regulatory factor of tumor necrosis alpha factor
06/02/2009US7541336 Prepared by culturing a microorganism belonging to fungi and having ability to produce FKI-1033 substance in a medium; use in agrochemicals, veterinary medicines and pharmaceuticals having an activity of ryanodine binding inhibition, an insecticidal and anthelmintic activity
06/02/2009US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα
06/02/2009CA2340416C Co-lyophilized complex of a nucleic acid vector and a formulating agent
05/2009
05/28/2009WO2008156610A3 Antibiotic compounds
05/28/2009US20090137778 A HIV peptide consisting of 23 to 50 amino acid residues; trans-activator
05/28/2009US20090136529 Compositions And Methods For Treatment, Research And Therapeutic Applications For Malaria
05/27/2009EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
05/27/2009EP2061499A2 Novel nematode protein and its use in producing anthelminthic agents and vaccines
05/27/2009EP2061309A2 Compositions and methods of use thereof for the removal of ticks from epidermal tissue
05/27/2009EP1567189B1 Malaria vaccine
05/27/2009EP1292678B1 G-protein coupled receptors
05/27/2009EP1130966B2 Antiparasitic formulations
05/27/2009CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
05/27/2009CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
05/27/2009CN100490803C Autoemulsified albendazole preparation and its preparation process
05/27/2009CN100490799C Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
05/26/2009CA2339495C Phospholipids with unsaturated alkyl and acyl chains
05/26/2009CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
05/22/2009WO2009040552A3 Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof
05/22/2009CA2703008A1 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
05/21/2009US20090131502 Biologically active compounds
05/21/2009US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
05/21/2009US20090131421 Compounds for proteasome enzyme inhibition
05/21/2009US20090131366 Use of Amine-Borane Compounds as Anti-Microbial Agents
05/21/2009US20090130233 Two part lotion
05/21/2009US20090130231 Pharmaceutical formulation for treating tinea of feet and hands and preparation thereof
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 218